The annual Optimizing PCI Outcomes symposium will
provide a comprehensive update on the latest clinical
breakthroughs in the percutaneous treatment of coronary
artery disease, with presentations on emerging clinical
trial data for current and second-generation drug-eluting
stent device-based therapies along with discussions on
the evolving treatment pathways such as FFR and IVUS for
procedural guidance and selection of antiplatelet therapy
to improve the outcomes of percutaneous intervention.
Utilizing both didactic and case-based presentations,
attendees will be exposed to the latest evidence-based
approaches to optimize patient outcomes in the treatment
of coronary artery disease.